Z

Zenas Biopharma Inc
NASDAQ:ZBIO

Watchlist Manager
Zenas Biopharma Inc
NASDAQ:ZBIO
Watchlist
Price: 19.4 USD 1.57% Market Closed
Market Cap: 771.9m USD
Have any thoughts about
Zenas Biopharma Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-17.5
Current
-16.7
Median
3.8
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-17.5
=
Enterprise Value
588m USD
/
FCFF
-33.7m USD
All Countries
Close
 
US
Z
Zenas Biopharma Inc
NASDAQ:ZBIO
Average EV/FCFF: 31.3
Negative Multiple: -17.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -235 459.5
US
Abbvie Inc
NYSE:ABBV
22.5
US
Amgen Inc
NASDAQ:AMGN
32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -84.4
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -476.4
AU
CSL Ltd
ASX:CSL
65.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -101.2

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More